Concepedia

Will Sawyer

WS

Statistics

Publications

6

Citations

177

H-Index

6

Active since

1999

Affiliations

Astellas Pharma (Netherlands)(Current)

Aarhus University Hospital

Will Sawyer is an author at Astellas Pharma (Netherlands) specializing in pharmacology, overactive bladder management, and pediatric clinical pharmacology.

Publications per year

1999–2019

6

Publications

6

Effects of First-Line Use of Nucleoside Analogues, Efavirenz, and Ritonavir-Boosted Protease Inhibitors on Lipid Levels

Andrew Hill, Will Sawyer, Brian Gazzard · HIV Clinical Trials · 2009 · 47 citations · Full text

, , +13

Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial

Donald Newgreen, Brigitte Bosman, Adriana Hollestein-Havelaar et al. · European Urology · 2016 · 42 citations

, , +13

Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction

Adam Lloyd, Richard Kennedy, Julia Hutchinson et al. · Fertility and Sterility · 2003 · 38 citations · Full text

, , +16

Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder

Donald Newgreen, Brigitte Bosman, Adriana Hollestein-Havelaar et al. · The Journal of Urology · 2017 · 25 citations

, , +17

A Prospective Cost-Consequence Analysis of Adding Lamivudine to Zidovudine-Containing Antiretroviral Treatment Regimens for HIV Infection in the US

L.F. Lacey, Josephine Mauskopf, Richard C. Lindrooth et al. · PharmacoEconomics · 1999 · 15 citations

, , +15

1–5 of 6